Yeah.. I would not mind getting back in at current price after bailing at 19.5 ... but will wait for the quarterly . If it is good, may need to pay a premium to todays price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025